MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$111,750K
Inventory, net
$74,234K
Trade accounts
receivable, net
$56,295K
Prepaid expenses and
other current assets
$9,403K
Total current assets
$251,682K
Intangible Assets Net
Excluding Goodwill
$85,368K
Goodwill
$22,859K
Operating lease
right-of-use assets
$21,949K
Other Assets
Noncurrent
$5,122K
Property and equipment,
net
$5,033K
Total assets
$392,013K
Total liabilities and
stockholders' equity
$392,013K
Total liabilities
$379,002K
Total stockholders'
equity
$13,011K
Accumulated deficit
-$669,073K
Accumulated other
comprehensive loss
-$24K
Debt, net of
unamortized debt issuance...
$221,224K
Total current
liabilities
$118,593K
Non-current operating lease
liabilities
$31,058K
Other liabilities
$8,127K
Additional paid in capital
$682,090K
Common stockpar value
0.0001, 350,000,000...
$18K
Accrued trade discounts
and rebates
$45,492K
Other accrued
liabilities
$32,287K
Accrued returns reserve
$18,723K
Accounts payable
$11,467K
Current operating lease
liabilities
$6,271K
Other current
liabilities
$4,353K
Back
Back
Balance Sheet
source: myfinsight.com
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS)